5. Earnings per Share

The following is a reconciliation between basic and diluted weighted average shares outstanding:

	13 Weeks Ended				26 Weeks Ended
	August 4,		July 29,		August 4,		July 29,
(In thousands)	2018		2017		2018		2017
Weighted average common shares outstanding:
Basic number of common shares outstanding		177,249		177,228		177,329		178,475
Dilutive effect of stock options and non-vested restricted stock		1,256		1,560		1,401		1,998
Diluted number of common shares outstanding		178,505		178,788		178,730		180,473

Equity awards to purchase approximately 0.7 million shares of common stock during both the 13 and 26 weeks ended August 4, 2018, respectively, and approximately 3.3 million shares of common stock during both the 13 and 26 weeks ended July 29, 2017 were outstanding, but were not included in the computation of weighted average diluted common share amounts as the effect of doing so would be anti-dilutive.

Additionally, approximately 0.7 million shares of restricted stock units for the 13 and 26 weeks ended August 4, 2018, and 1.3 million shares of restricted stock units for the 13 and 26 weeks ended July 29, 2017,were outstanding, but not included in the computation of weighted average diluted common share amounts as the effect of doing so would be anti-dilutive. Furthermore, approximately 1.1 million and 1.4 million shares of restricted stock units for the 13 and 26 weeks ended August 4, 2018, respectively, and 0.6 million shares of restricted stock units for both the 13 and 26 weeks ended July 29, 2017, respectively, were not included in the computation of weighted average diluted common shares amounts because the number of shares ultimately issued is contingent on the Company’s performance compared to pre-established annual performance goals.

Refer to Note 9 to the Consolidated Financial Statements for additional information regarding share-based compensation.